Enantioselective Synthesis of 3,3-Difluoropyrrolidin-4-ol, a Valuable Building Block in Medicinal Chemistry.

J Org Chem

DCR&T, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.

Published: May 2016

In this paper, we report for the first time two enantioselective routes to 4,4-difluoropyrrolidin-3-ol, a valuable building block in medicinal chemistry. In the first route, we took advantage of the C2 symmetry of (3R,4R)-3,4-dihydroxypyrrolidine in which the desired chirality was derived from the chiral pool (l-(+)-tartaric acid). In the second route, we efficiently assembled the pyrrolidine ring in the presence of a gem-difluoro moiety to avoid using potentially hazardous deoxofluorinating reagents and subsequently introduced the chirality by a stereoselective iridium-diamine-catalyzed asymmetric transfer hydrogenation reaction.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.6b00305DOI Listing

Publication Analysis

Top Keywords

valuable building
8
building block
8
block medicinal
8
medicinal chemistry
8
enantioselective synthesis
4
synthesis 33-difluoropyrrolidin-4-ol
4
33-difluoropyrrolidin-4-ol valuable
4
chemistry paper
4
paper report
4
report time
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!